Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Mar 6 2000
Dallas, Texas (March 6, 2000) The Biotechnology Industry Organization (BIO) has named Texas Rep. Brian McCall (R-Plano) as BIO State Legislator of the Year...
Mar 1 2000
WASHINGTON, D.C. (March 1, 2000) In addition to health care, biotechnology's impact on the environment, industrial manufacturing and agriculture will be...
Feb 29 2000
WASHINGTON, D.C. (February 29, 2000) -- The Biotechnology Industry Organization (BIO) has placed on its website (www.bio.org) a BIO 2000 News Room to provide...
Feb 25 2000
WASHINGTON, D.C. (February 25, 2000) Genomics has captured the attention of Wall Street investors and the imagination of others worldwide as researchers near...
Feb 23 2000
WASHINGTON, D.C. (February 23, 2000) The BiotechnologyIndustry Organization (BIO) issued the following statement in response to the bill introduced by U.S....
Feb 17 2000
EXECUTIVE SUMMARY BIO represents over 850 biotechnology companies, academic institutions, state biotechnology centers, and related organizations in 46 states...
Feb 14 2000
WASHINGTON, D.C. (February 14, 2000) - Christopher Reeve, paralyzed five years ago after a fall during an equestrian competition, will discuss his life and...
Feb 10 2000
WASHINGTON, D.C. (February 11, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a...
Feb 8 2000
WASHINGTON, D.C. (February 8, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today on...


Biotechnology News

September 1, 2014

RYDALMERE, Australia--(BUSINESS WIRE)--Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today introduced...

September 1, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced top-line results from the final analysis of COMET-1, the phase 3 pivotal trial...

September 1, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate announced the appointment of Alex Karle to the role of Chief Executive Officer. Dr Jonathan de Pass, founder and...

September 1, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US/Non-UK/Non-Canadian Media Five years on from the first breakthrough presentation of the pivotal RE-LY® clinical trial of...

September 1, 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (...